long acting Injection [Design Issues]

posted by jag009  – NJ, 2020-04-21 21:06  – Posting: # 21342
Views: 298

Hi,

» But if it is mentioned in monograph that half-life is 17 days following single dose and 46 days after multiple dose, then which half-life we should consider while designing multiple dose study? In the same monograph, it is also stated that steady state is achieved after 4th dose on injection.

Have you found out why the increase in half-life?

J

Complete thread:

Activity
 Admin contact
20,643 posts in 4,328 threads, 1,436 registered users;
online 20 (0 registered, 20 guests [including 11 identified bots]).
Forum time: 09:53 CEST (Europe/Vienna)

No one should approach the temple of science
with the soul of a money changer.    Thomas Browne

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5